India says Johnson & Johnson interested in making COVID-19 vaccine in country
India also currently has no concern over the efficacy of the AstraZeneca vaccine that is being used in the country's massive inoculation campaign, Vinod Kumar Paul said.
By Reuters | Updated:
NEW DELHI: Johnson & Johnson is interested in manufacturing its COVID-19 vaccine in India, a government official told a news conference on Tuesday.
India also currently has no concern over the efficacy of the AstraZeneca vaccine that is being used in the country's massive inoculation campaign, Vinod Kumar Paul said.
India also currently has no concern over the efficacy of the AstraZeneca vaccine that is being used in the country's massive inoculation campaign, Vinod Kumar Paul said.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
Related Articles
Johnson & Johnson beats lawsuit alleging that talc caused three women's cancer2026-06-06T00:57:37Z- Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage study2026-05-31T12:08:39Z
- US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims2026-04-18T02:24:28Z
ADVERTISEMENT
